Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Immunomedics reports phase II results of CEA-Cide as colorectal cancer therapy

June 7, 2000

Progenics to continue GMK cancer vaccine trial as an extension study

June 2, 2000

CPMP recommends approval of Herceptin for treatment of metastatic breast cancer

May 29, 2000

Single doses of HspE7 are well tolerated and elicit specific cell-mediated immunity

May 29, 2000

New fusion toxin with therapeutic potential in acute-phase CML presented at ASCO

May 29, 2000

Phase I trial of Hu1D10 continues following positive results in first lymphoma patients treated

May 29, 2000

Antisoma temporarily halts Theragyn phase III enrollment

May 29, 2000

News from ASCO: Medarex's MDX-210 may be useful in breast cancer and ovarian cancer

May 26, 2000

Vaccination with ras peptides as therapeutic strategy in pancreatic cancer

May 26, 2000

Cell Genesys reports encouraging preclinical data for leukemia vaccine

May 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...